Volume 69, Issue 4, Pages 982-984 (October 2018) Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany  Kerstin Herzer, Guido Gerken, Daniela Kroy, Frank Tacke, Julius Plewe, Dennis Eurich, Ulrich Spengler, Christian P. Strassburg, Martin- Walter Welker, Sven Pischke, Martina Sterneck, Arianeb Mehrabi, Karl Heinz Weiss, Adam Herber, Thomas Berg, Tim Zimmermann, Peter R. Galle, Hauke Heinzow, Hartmut Schmidt, Antoaneta Markova, Yvonne Serfert, Michael P. Manns, Stefan Zeuzem, Heiner Wedemeyer  Journal of Hepatology  Volume 69, Issue 4, Pages 982-984 (October 2018) DOI: 10.1016/j.jhep.2018.07.001 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Liver transplantation and waiting list trends in patients with HCV infection. Development of the percentage of patients (A) on the LT waiting list with HCV cirrhosis and (B) who received LT due to HCV cirrhosis; (C) SVR rates in patients on the waiting list; (D) patients who achieve SVR on the waiting list but remain in need of LT; (E) number of patients delisted due to SVR or decompensation; (F) proportion of patients with HCV-associated HCC at time of listing and time of LT. HCV; hepatitis C virus; LT, liver transplantation; SVR, sustained virologic response. Journal of Hepatology 2018 69, 982-984DOI: (10.1016/j.jhep.2018.07.001) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions